Peptide-Propofol Prodrug with Self-Assembly and Triggered Release for Antidepressant Therapy
ACS Applied Materials & Interfaces · 2026
DOI: 10.1021/acsami.6c06335 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, 2026. Verfasst von Dan Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry and Psychosomatics, Zhongda Hospital, School of Medicine, Jiangsu Provincial Key Laboratory of Brain Science and Medicine, S…. Hauptthemen laut MEDLINE: Propofol, Prodrugs, Antidepressive Agents, Peptides. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: Ministry of Education of the People's Republic of China, Ministry of Science and Technology of the People's Republic of China, Natural Science Foundation of Jiangsu Province.
Abstract (Originalsprache)
Major depressive disorder (MDD) remains difficult to treat with agents that are simultaneously rapid, durable, and well-tolerated. Propofol shows fast antidepressant-like actions but is limited by anesthetic liability, a short half-life, and poor brain-selective exposure. Here, we report Nap-FFYK(propofol), a peptide-propofol self-assembling prodrug engineered to decouple anesthetic burden from sustained antidepressant benefit. Physicochemical characterization confirmed the stimulus-triggered conversion of Nap-FFYK(propofol) to Nap-FFYK and propofol. The prodrug displays high drug loading, robust self-assembly into nanospheres, and carboxylesterase (CES)-responsive release, enabling on-site liberation of propofol with a lower risk of respiratory depression. In the chronic social defeat stress mouse model, a single administration produced rapid and durable antidepressant-like effects with a swift recovery from transient sedation. Mechanistic analyses demonstrated reduced microglial activation, restored astrocytic support, preserved blood-brain barrier integrity, and enhanced synaptic plasticity in hippocampal circuits. These findings validate a targeting-assembly release strategy for propofol repurposing and establish peptide self-assembly prodrugs as a tractable platform for brain-directed, rapid-acting antidepressant therapy. This approach provides a blueprint to pair hour-scale symptom relief with improved safety and durability, addressing key limitations of existing rapid-acting interventions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Psychiatry and Psychosomatics, Zhongda Hospital, School of Medicine, Jiangsu Provincial Key Laboratory of Brain Science and Medicine, Southeast University, Nanjing, Jiangsu 210009, China.
- State Key Laboratory of Digital Medical Engineering, School of Biological Science and Medical Engineering, Southeast University, Nanjing, Jiangsu 211189, China.
- Department of Pharmacology, Jiangsu Provincial Key Laboratory of Critical Care Medicine, School of Medicine, Southeast University, Nanjing, Jiangsu 210009, China.
- Institute of Life Sciences, Key Laboratory of Developmental Genes and Human Disease, Southeast University, Nanjing, Jiangsu 210009, China.
ORCID-Profile: Xianbao Sun, Honghong Yao
Förderung
- Ministry of Education of the People's Republic of China
- Ministry of Science and Technology of the People's Republic of China
- Natural Science Foundation of Jiangsu Province
- Science and Technology Support Program of Jiangsu Province
- Jiangsu Province High-Level Hospital Construction Funds of Zhongda Hospital
- National Natural Science Foundation of China (NSFC)
Zitieren
APA
Wang, D., Yuan, Z., Sun, X., Shen, L., Yuan, Y., Jia, Y., & Yao, H. (2026). Peptide-Propofol Prodrug with Self-Assembly and Triggered Release for Antidepressant Therapy. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.6c06335
Vancouver
Wang D, Yuan Z, Sun X, Shen L, Yuan Y, Jia Y, et al. Peptide-Propofol Prodrug with Self-Assembly and Triggered Release for Antidepressant Therapy. ACS Applied Materials & Interfaces. 2026. doi:10.1021/acsami.6c06335
BibTeX
@article{Wang2026,
author = {Wang, Dan and Yuan, Zihan and Sun, Xianbao and Shen, Ling and Yuan, Yonggui and Jia, Yanpeng and Yao, Honghong},
title = {Peptide-Propofol Prodrug with Self-Assembly and Triggered Release for Antidepressant Therapy},
journal = {ACS Applied Materials & Interfaces},
year = {2026},
doi = {10.1021/acsami.6c06335}
}
EUVIMED